Medexus Pharmaceuticals Inc (TSX:MDP)

C$ 3.25 0.2 (6.56%) Market Cap: 80.12 Mil Enterprise Value: 131.88 Mil PE Ratio: 22.73 PB Ratio: 1.81 GF Score: 53/100

Q2 2025 Medexus Pharmaceuticals Inc Earnings Call Transcript
Nov 08, 2024

C$2.17 (-1.36%)

Earnings
Q1 2025 Medexus Pharmaceuticals Inc Earnings Call Transcript
Aug 08, 2024

C$2.46 (+8.37%)

Earnings
Q4 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Jun 26, 2024

C$1.72 (+1.78%)

Earnings
Q3 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Feb 08, 2024

C$1.92 (-28.89%)

Earnings
Q2 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Nov 09, 2023

C$2 (-2.44%)

Earnings
Medexus Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Sep 21, 2023
Medexus Pharmaceuticals Inc at Openexchange Share Series (Virtual) Transcript
Aug 14, 2023
Q1 2024 Medexus Pharmaceuticals Inc Earnings Call Transcript
Aug 10, 2023

C$2.92 (-0.34%)

Earnings
Q4 2023 Medexus Pharmaceuticals Inc Earnings Call Transcript
Jun 22, 2023

C$1.4 (+12.90%)

Earnings
Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Apr 25, 2023
Q3 2023 Medexus Pharmaceuticals Inc Earnings Call Transcript
Feb 09, 2023

C$1.8 (-1.10%)

Earnings
Q2 2023 Medexus Pharmaceuticals Inc Earnings Call Transcript
Nov 09, 2022

C$1.78 (-26.45%)

Earnings
Medexus Pharmaceuticals Inc Investor Update Call Transcript
Sep 21, 2022
Medexus Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Sep 15, 2022
Q1 2023 Medexus Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2022

C$2.95 (+18.00%)

Earnings
Q4 2022 Medexus Pharmaceuticals Inc Earnings Call Transcript
Jun 23, 2022

C$1.95 (-9.30%)

Earnings
Medexus Pharmaceuticals Inc to Discuss Treosulfan Data Transcript
Jun 06, 2022
Q3 2022 Medexus Pharmaceuticals Inc Earnings Call Transcript
Feb 10, 2022

C$3.27 (+5.48%)

Earnings
Medexus Pharmaceuticals Inc at Issuer Direct Winter Wonderland Best Ideas Investor Conference (Virtual) Transcript
Feb 08, 2022
Medexus Pharmaceuticals Inc at SNN Network Canada Virtual Event Transcript
Dec 08, 2021
Medexus Pharmaceuticals Inc at Benzinga Global Small Cap Conference (Virtual) Transcript
Oct 28, 2021
Medexus Pharmaceuticals Inc at SNN Network Summer Event (Virtual) Transcript
Aug 19, 2021

Q2 2025 Medexus Pharmaceuticals Inc Earnings Call Transcript

Nov 08, 2024 / 01:00PM GMT

Release Date Price: C$2.17 (-1.36%)

Transcript

Operator

Good morning, everyone and welcome to the Medexus Pharmaceuticals second quarter, 2025 conference call at this time. All participants are in a listen-only mode and we will open for questions following the presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Victoria Rutherford Investor Relations. Victoria, the floor is yours.

Victoria Rutherford

Medexus Pharmaceuticals Inc - IR Contact Officer

Thank you and good morning, everyone. Welcome to the Medexus Pharmaceuticals second fiscal quarter 2025 earnings call on the call this morning are Ken D'entermont, Chief Executive Officer and Brendon Buschman, Chief Financial Officer. If you have any questions after the call or would like further information about the company, please contact Adelaide Capital at 4806255772. I would like to remind everyone that this discussion will include forward-looking information as defined in securities laws.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.